Pharmacyte Biotech Inc Share Price Other OTC
Equities
US67090R1005
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 50.93M 4.25B |
---|---|---|---|---|---|
Net income 2022 | -4M -334M | Net income 2023 | -4M -334M | EV / Sales 2022 | - |
Net cash position 2022 | 85.4M 7.13B | Net cash position 2023 | 68.04M 5.68B | EV / Sales 2023 | - |
P/E ratio 2022 |
-8.53
x | P/E ratio 2023 |
-13.2
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.95% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Silverman
CEO | Chief Executive Officer | 54 | 15/22/15 |
Carlos Trujillo
DFI | Director of Finance/CFO | 66 | 01/15/01 |
José Iglesias
CTO | Chief Tech/Sci/R&D Officer | - | 10/20/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Weinstein
BRD | Director/Board Member | 64 | 14/22/14 |
Joshua Silverman
CEO | Chief Executive Officer | 54 | 15/22/15 |
Wayne Walker
BRD | Director/Board Member | 65 | 28/22/28 |
1st Jan change | Capi. | |
---|---|---|
+51.54% | 795B | |
+40.81% | 627B | |
-7.20% | 350B | |
+18.67% | 328B | |
+7.48% | 294B | |
+17.58% | 245B | |
+0.94% | 222B | |
+11.63% | 215B | |
+3.64% | 160B |